Cliquez pour voir la ligne de temps
Ligne de temps
Projets
Anciennes Équipes
Publications
Télécharger-
2025Multimodal SARS-CoV-2 interactome sketches the virus-host spatial organization., Commun Biol 2025 Mar; 8(1): 501.
-
2024Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2., iScience 2024 Jul; 27(7): 110354.
-
2024Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion., Nat Commun 2024 Mar; 15(1): 2254.
-
2023Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages., iScience 2023 Apr; 26(4): 106413.
-
2023SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19., EMBO Rep 2023 Apr; 24(4): e56055.
-
2022Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen., Nat Commun 2022 May; 13(1): 2442.
-
2022Bat coronaviruses related to SARS-CoV-2 and infectious for human cells., Nature 2022 Apr; 604(7905): 330-336.
-
2022A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection., EMBO Rep 2022 Feb; 23(2): e54341.
-
2021Coronaviruses with a SARS-CoV-2-like receptor-binding domain allowing ACE2-mediated entry into human cells isolated from bats of Indochinese peninsula, 2021.
-
2021Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies., Nat Med 2021 May; 27(5): 917-924.
-
+Voir la liste complète de publications